Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Changes in adherence to composite outcome over time (2013–2017) by participation in QASC/QASCIP and the presence of a stroke unit

From: Inclusion of a care bundle for fever, hyperglycaemia and swallow management in a National Audit for acute stroke: evidence of upscale and spread

  2015 vs 2013a 2017 vs 2015a 2017 vs 2013a
  OR (95% CI) p valueb OR (95% CI) p valueb OR (95% CI) p valueb
Participation in QASC/QASCIP
 Participatedc 1.2 (0.95, 1.6) 0.4 1.7 (1.4, 2.0) 0.4 2.1 (1.7, 2.7) 0.03
 Not participatedc 1.1 (0.93, 1.2) 1.5 (1.4, 1.7) 1.6 (1.4, 1.8)
Presence of a stroke unit
 Yes 1.0 (0.93, 1.2) 0.051 1.7 (1.5, 1.8) 0.09 1.7 (1.5, 1.9) 0.6
 No 1.4 (1.04, 1.9) 1.4 (1.0, 1.8) 1.9 (1.4, 2.6)
  1. Dependent variable is adherence to composite outcome measure; independent variables include interaction term between year/participation QASC/QASCIP or year/stroke unit presence, adjusted for correlation within hospital. OR Odds Ratio, CI Confidence Interval
  2. aReference year
  3. bFor the interaction term
  4. cParticipated in QASC or QASCIP